4.7 Review

A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment

期刊

JOURNAL OF CLINICAL MEDICINE
卷 9, 期 11, 页码 -

出版社

MDPI
DOI: 10.3390/jcm9113529

关键词

tumor microenvironment; immune system; neurotropic carcinoma; neurogenesis; exosomes; microRNAs

资金

  1. Fondazione CRT grant [Rif 2018.0648]
  2. Oncobiome European H2020 research project [825410]
  3. National Institutes of Health (NIH/NCATS) through the NIH Common Fund, Office of Strategic Coordination (OSC) [UH3TR00943-01]
  4. NCI [1R01 CA182905-01, 1R01CA222007-01A1]
  5. NIGMS [1R01GM122775-01]
  6. Team DOD grant [CA160445P1]
  7. Chronic Lymphocytic Leukemia Moonshot Flagship project
  8. CLL Global Research Foundation 2019 grant
  9. CLL Global Research Foundation 2020 grant
  10. CDMRP [917395, CA160445P1] Funding Source: Federal RePORTER

向作者/读者索取更多资源

One of the limitations of cancer research has been the restricted focus on tumor cells and the omission of other non-malignant cells that are constitutive elements of this systemic disease. Current research is focused on the bidirectional communication between tumor cells and other components of the tumor microenvironment (TME), such as immune and endothelial cells, and nerves. A major success of this bidirectional approach has been the development of immunotherapy. Recently, a more complex landscape involving a multi-lateral communication between the non-malignant components of the TME started to emerge. A prime example is the interplay between immune and endothelial cells, which led to the approval of anti-vascular endothelial growth factor-therapy combined with immune checkpoint inhibitors and classical chemotherapy in non-small cell lung cancer. Hence, a paradigm shift approach is to characterize the crosstalk between different non-malignant components of the TME and understand their role in tumorigenesis. In this perspective, we discuss the interplay between nerves and immune cells within the TME. In particular, we focus on exosomes and microRNAs as a systemic, rapid and dynamic communication channel between tumor cells, nerves and immune cells contributing to cancer progression. Finally, we discuss how combinatorial therapies blocking this tumorigenic cross-talk could lead to improved outcomes for cancer patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据